{'fraction_non_alphanumeric': 0.007863695937090432, 'fraction_numerical': 0.001310615989515072, 'mean_word_length': 5.701754385964913, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pain experience in patients with cerebral palsy in the two days following botulinum toxin injections

younger patients and those with Type 1 SMA. Procedure related complications were seen in older patients and those with previously instrumented spines. This demonstrates the need for exploration of alternative delivery systems such as implanted reservoirs for these patients. The lack of laboratory abnormalities suggests that the frequency of laboratory testing may be decreased. The improvement or stability of motor control and subjective increased functionality in most patients indicates Spinraza is an effective medication. The maintained or reduced level of ventilatory support in several patients suggests Spinraza improves muscular control of breathing.